diabetes Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity to raise awareness, with for instance their current MoU with the ministry of health: “This program will be showcased worldwide and will serve as a benchmark and example of how collaboration between the…
medical tourism Malaysia Healthcare Travel Council’s CEO is proud of her country’s healthcare system and their efforts at attracting medical tourists from all over the world, with the support of the healthcare NKEA and the government’s efforts to become a reference in healthcare worldwide. Medical tourism has been a national…
pain management Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year. Mundipharma has recently entered a booming Malaysian pharmaceutical sector. What are your first impressions of the Malaysian market? Malaysia’s pharmaceutical sector…
CNS Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to be overlooked.” While this is a challenge, it also represents an opportunity for Lundbeck to provide best-in-line products to patients.…
insulin The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of local companies is small, and multinational companies large: exactly the opposite of the Argentinian model. In 2002, the former minister of health, Gines Gonzalez, created the generics…
distribution Although Chile is a relatively small market, with only 17 million inhabitants, its geography makes it a challenging environment for logistics and distribution services. Chile stretches over 4,300 km along the southwest coast of South America, a distance roughly the same as that from San Francisco to New York. At…
Pfizer Edgardo Vázquez, Pfizer’s country manager for the Argentina Region, discusses the company’s investment strategies across their newly established business units and a few of the unique challenges presented by the Argentinean market. How have Pfizer’s goals for Argentina changed over the last few years, and what is your strategy…
medical devices The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter into the medical device market and most important, where did you see the opportunities when creating this company? From the…
regulation Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview of ANMAT, its main achievements and current activities today? Since its creation in 1992, ANMAT has performed activities intended for…
UAE How quickly can a country truly transform its healthcare system, while making it sustainable for the future? The mindset of Emiratis is that anything that is feasible and beneficial for the country should and will be done, regardless of the cost. This is why health authorities have been moving at…
doctors MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and strong government support. However, the situation could change as too many doctors change to the private sector, NCDs are drastically increasing and financing healthcare…
IMS IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces this landmark and also shares the opportunities present for pharma companies to invest in Malaysia. IMS is now providing data for the…
See our Cookie Privacy Policy Here